Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laura A. Rabin is active.

Publication


Featured researches published by Laura A. Rabin.


Alzheimers & Dementia | 2014

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Frank Jessen; Rebecca Amariglio; Martin P. J. van Boxtel; Monique M.B. Breteler; Mathieu Ceccaldi; Gaël Chételat; Bruno Dubois; Carole Dufouil; K. Ellis; Wiesje M. van der Flier; Lidia Glodzik; Argonde C. van Harten; Mony J. de Leon; Pauline McHugh; Michelle M. Mielke; José Luis Molinuevo; Lisa Mosconi; Ricardo S. Osorio; Audrey Perrotin; Ronald C. Petersen; Laura A. Rabin; Lorena Rami; Barry Reisberg; Dorene M. Rentz; Perminder S. Sachdev; Vincent de La Sayette; Andrew J. Saykin; Philip Scheltens; Melanie B. Shulman; Melissa J. Slavin

There is increasing evidence that subjective cognitive decline (SCD) in individuals with unimpaired performance on cognitive tests may represent the first symptomatic manifestation of Alzheimers disease (AD). The research on SCD in early AD, however, is limited by the absence of common standards. The working group of the Subjective Cognitive Decline Initiative (SCD‐I) addressed this deficiency by reaching consensus on terminology and on a conceptual framework for research on SCD in AD. In this publication, research criteria for SCD in pre‐mild cognitive impairment (MCI) are presented. In addition, a list of core features proposed for reporting in SCD studies is provided, which will enable comparability of research across different settings. Finally, a set of features is presented, which in accordance with current knowledge, increases the likelihood of the presence of preclinical AD in individuals with SCD. This list is referred to as SCD plus.


Neurology | 2006

Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI

Andrew J. Saykin; Heather A. Wishart; Laura A. Rabin; Robert B. Santulli; Laura A. Flashman; John D. West; Tara L. McHugh; Alexander C. Mamourian

Objective: To examine the neural basis of cognitive complaints in healthy older adults in the absence of memory impairment and to determine whether there are medial temporal lobe (MTL) gray matter (GM) changes as reported in Alzheimer disease (AD) and amnestic mild cognitive impairment (MCI). Methods: Participants were 40 euthymic individuals with cognitive complaints (CCs) who had normal neuropsychological test performance. The authors compared their structural brain MRI scans to those of 40 patients with amnestic MCI and 40 healthy controls (HCs) using voxel-based morphometry and hippocampal volume analysis. Results: The CC and MCI groups showed similar patterns of decreased GM relative to the HC group on whole brain analysis, with differences evident in the MTL, frontotemporal, and other neocortical regions. The degree of GM loss was associated with extent of both memory complaints and performance deficits. Manually segmented hippocampal volumes, adjusted for age and intracranial volume, were significantly reduced only in the MCI group, with the CC group showing an intermediate level. Conclusions: Cognitive complaints in older adults may indicate underlying neurodegenerative changes even when unaccompanied by deficits on formal testing. The cognitive complaint group may represent a pre–mild cognitive impairment stage and may provide an earlier therapeutic opportunity than mild cognitive impairment. MRI analysis approaches incorporating signal intensity may have greater sensitivity in early preclinical stages than volumetric methods.


Neurology | 2006

Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele

Heather A. Wishart; Andrew J. Saykin; Thomas W. McAllister; Laura A. Rabin; Brenna C. McDonald; Laura A. Flashman; Robert M. Roth; Alexander C. Mamourian; Gregory J. Tsongalis; C. H. Rhodes

Objective: To determine whether cognitively intact adults with the APOE ε3/ε4 genotype show reduced gray matter density on voxel-based morphometry (VBM) vs those homozygous for the ε3 allele. Methods: Participants were healthy, cognitively intact, right-handed adults, age 19 to 80, who completed genotyping, neuropsychological testing, and MRI. Forty-nine participants had the ε3/ε3 genotype and 27 had the ε3/ε4 genotype. Gray matter data were analyzed using the general linear model as implemented in the Statistical Parametric Mapping package, adjusting for age and sex. Results: The ε3/ε4 participants showed lower gray matter density than the ε3/ε3 participants in right medial temporal and bilateral frontotemporal regions as well as other areas. There were no regions in which ε3/ε4 participants showed higher gray matter density than ε3/ε3 participants. Conclusions: Regionally reduced gray matter density is detectable in cognitively intact adults with a single copy of the APOE ε4 allele.


Archives of Clinical Neuropsychology | 2008

Verbal fluency performance in amnestic MCI and older adults with cognitive complaints

Katherine E. Nutter-Upham; Andrew J. Saykin; Laura A. Rabin; Robert M. Roth; Heather A. Wishart; Nadia Pare; Laura A. Flashman

Verbal fluency tests are employed regularly during neuropsychological assessments of older adults, and deficits are a common finding in patients with Alzheimers disease (AD). Little extant research, however, has investigated verbal fluency ability and subtypes in preclinical stages of neurodegenerative disease. We examined verbal fluency performance in 107 older adults with amnestic mild cognitive impairment (MCI, n=37), cognitive complaints (CC, n=37) despite intact neuropsychological functioning, and demographically matched healthy controls (HC, n=33). Participants completed fluency tasks with letter, semantic category, and semantic switching constraints. Both phonemic and semantic fluency were statistically (but not clinically) reduced in amnestic MCI relative to cognitively intact older adults, indicating subtle changes in the quality of the semantic store and retrieval slowing. Investigation of the underlying constructs of verbal fluency yielded two factors: Switching (including switching and shifting tasks) and Production (including letter, category, and action naming tasks), and both factors discriminated MCI from HC albeit to different degrees. Correlational findings further suggested that all fluency tasks involved executive control to some degree, while those with an added executive component (i.e., switching and shifting) were less dependent on semantic knowledge. Overall, our findings highlight the importance of including multiple verbal fluency tests in assessment batteries targeting preclinical dementia populations and suggest that individual fluency tasks may tap specific cognitive processes.


Aging Neuropsychology and Cognition | 2009

Differential Memory Test Sensitivity for Diagnosing Amnestic Mild Cognitive Impairment and Predicting Conversion to Alzheimer's Disease

Laura A. Rabin; Nadia Pare; Andrew J. Saykin; Michael J. Brown; Heather A. Wishart; Laura A. Flashman; Robert B. Santulli

ABSTRACT Episodic memory is the first and most severely affected cognitive domain in Alzheimers disease (AD), and it is also the key early marker in prodromal stages including amnestic mild cognitive impairment (MCI). The relative ability of memory tests to discriminate between MCI and normal aging has not been well characterized. We compared the classification value of widely used verbal memory tests in distinguishing healthy older adults (n = 51) from those with MCI (n = 38). Univariate logistic regression indicated that the total learning score from the California Verbal Learning Test-II (CVLT-II) ranked highest in terms of distinguishing MCI from normal aging (sensitivity = 90.2; specificity = 84.2). Inclusion of the delayed recall condition of a story memory task (i.e., WMS-III Logical Memory, Story A) enhanced the overall accuracy of classification (sensitivity = 92.2; specificity = 94.7). Combining Logical Memory recognition and CVLT-II long delay best predicted progression from MCI to AD over a 4-year period (accurate classification = 87.5%). Learning across multiple trials may provide the most sensitive index for initial diagnosis of MCI, but inclusion of additional variables may enhance overall accuracy and may represent the optimal strategy for identifying individuals most likely to progress to dementia.


Neurobiology of Aging | 2006

Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints

Paul Wang; Andrew J. Saykin; Laura A. Flashman; Heather A. Wishart; Laura A. Rabin; Robert B. Santulli; Tara L. McHugh; John W. MacDonald; Alexander C. Mamourian

The goal of the present study was to determine if there are global or regionally specific decreases in callosal area in early Alzheimers disease (AD) and mild cognitive impairment (MCI). In addition, this study examined the corpus callosum of healthy older adults who have subjective cognitive complaints (CC) but perform within normal limits on neuropsychological tests. We used a semi-automated procedure to examine the total and regional areas of the corpus callosum in 22 patients with early AD, 28 patients with amnestic MCI, 28 healthy older adults with cognitive complaints, and 50 demographically matched healthy controls (HC). The AD, MCI, and CC groups all showed a significant reduction of the posterior region (isthmus and splenium) relative to healthy controls. The AD group also had a significantly smaller overall callosum than the controls. The demonstration of callosal atrophy in older adults with cognitive complaints suggests that callosal changes occur very early in the dementing process, and that these earliest changes may be too subtle for detection by neuropsychological assessments, including memory tests.


Journal of the American Geriatrics Society | 2012

Predicting Alzheimer's disease: neuropsychological tests, self-reports, and informant reports of cognitive difficulties.

Laura A. Rabin; Cuiling Wang; Mindy J. Katz; Carol A. Derby; Herman Buschke; Richard B. Lipton

To investigate the independent and combined contributions to the risk of Alzheimers disease (AD) of three important domains of cognitive assessment: neuropsychological measurement, self‐reports, and informant reports.


Biochimica et Biophysica Acta | 2012

Selective Changes in White Matter Integrity in MCI and Older Adults with Cognitive Complaints

Yang Wang; John D. West; Laura A. Flashman; Heather A. Wishart; Robert B. Santulli; Laura A. Rabin; Nadia Pare; Konstantinos Arfanakis; Andrew J. Saykin

BACKGROUND White matter changes measured using diffusion tensor imaging have been reported in Alzheimers disease and amnestic mild cognitive impairment, but changes in earlier pre-mild cognitive impairment stages have not been fully investigated. METHODS In a cross-sectional analysis, older adults with mild cognitive impairment (n=28), older adults with cognitive complaints but without psychometric impairment (n=29) and healthy controls (n=35) were compared. Measures included whole-brain diffusion tensor imaging, T1-weighted structural magnetic resonance imaging, and neuropsychological assessment. Diffusion images were analyzed using Tract-Based Spatial Statistics. Voxel-wise fractional anisotropy and mean, axial, and radial diffusivities were assessed and compared between groups. Significant tract clusters were extracted in order to perform further region of interest comparisons. Brain volume was estimated using FreeSurfer based on T1 structural images. RESULTS The mild cognitive impairment group showed lower fractional anisotropy and higher radial diffusivity than controls in bilateral parahippocampal white matter. When comparing extracted diffusivity measurements from bilateral parahippocampal white matter clusters, the cognitive complaint group had values that were intermediate to the mild cognitive impairment and healthy control groups. Group difference in diffusion tensor imaging measures remained significant after controlling for hippocampal atrophy. Across the entire sample, diffusion tensor imaging indices in parahippocampal white matter were correlated with memory function. CONCLUSIONS These findings are consistent with previous results showing changes in parahippocampal white matter in Alzheimers disease and mild cognitive impairment compared to controls. The intermediate pattern found in the cognitive complaint group suggests the potential of diffusion tensor imaging to contribute to earlier detection of neurodegenerative changes during prodromal stages. This article is part of a Special Issue entitled: Imaging Brain Aging and Neurodegenerative disease.


Archives of Clinical Neuropsychology | 2016

Stability in Test-Usage Practices of Clinical Neuropsychologists in the United States and Canada Over a 10-Year Period: A Follow-Up Survey of INS and NAN Members

Laura A. Rabin; Emily Paolillo; William B. Barr

As a 10-year follow up to our original study (Rabin, Barr, & Burton, 2005), we surveyed the test usage patterns of clinical neuropsychologists in the U.S and Canada. We expanded the original questionnaire to include additional cognitive and functional domains and to address current practice-related issues. Participants were randomly selected from the combined membership lists of the National Academy of Neuropsychology and the International Neuropsychological Society. Respondents were 512 doctorate-level members (25% usable response rate; 54% women) who had been practicing neuropsychology for 15 years on average. The Wechsler Adult Intelligence Scales, followed by the Wechsler Memory Scales, Trail Making Test, California Verbal Learning Test, and Wechsler Intelligence Scale for Children, were the most commonly used tests. These top five responses were identical and in the same order as those from 10 years ago. Participants respectively identified a lack of ecological validity and difficulty comparing the meaning of standardized scores across tests as the greatest challenges associated with the selection of neuropsychological instruments and interpretation of test data. Overall, we found great consistency in assessment practices over the 10-year period. We compare results to those of previous studies and discuss challenges and implications for neuropsychology.


Neurobiology of Aging | 2013

Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints

Shannon L. Risacher; Darrell WuDunn; Susan M. Pepin; Tamiko R. MaGee; Brenna C. McDonald; Laura A. Flashman; Heather A. Wishart; Heather S. Pixley; Laura A. Rabin; Nadia Pare; Jessica J. Englert; Eben S. Schwartz; Joshua R. Curtain; John D. West; Darren P. O’Neill; Robert B. Santulli; Richard W. Newman; Andrew J. Saykin

Deficits in contrast sensitivity (CS) have been reported in Alzheimers disease (AD). However, the extent of these deficits in prodromal AD stages, including mild cognitive impairment (MCI) or even earlier, has not been investigated. In this study, CS was assessed using frequency doubling technology in older adults with AD (n = 10), amnestic MCI (n = 28), cognitive complaints without performance deficits (CC; n = 20), and healthy controls (HC; n = 29). The association between CS and cognition was also evaluated. Finally, the accuracy of CS measures for classifying MCI versus HC was evaluated. CS deficits were found in AD and MCI, while CC showed intermediate performance between MCI and HC. Upper right visual field CS showed the most significant difference among groups. CS was also associated with cognitive performance. Finally, CS measures accurately classified MCI versus HC. The CS deficits in AD and MCI, and intermediate performance in CC, indicate that these measures are sensitive to early AD-associated changes. Therefore, frequency doubling technology-based measures of CS may have promise as a novel AD biomarker.

Collaboration


Dive into the Laura A. Rabin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mindy J. Katz

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar

Richard B. Lipton

Albert Einstein College of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cuiling Wang

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge